ADRIBLASTINE

Brand name authorized in: France Tunisia

Active ingredients

The drug ADRIBLASTINE contains one active pharmaceutical ingredient (API):

1 Doxorubicin
UNII 82F2G7BL4E - DOXORUBICIN HYDROCHLORIDE

Doxorubicin is a cytotoxic anthracycline antibiotic obtained from Streptomyces peucetius var. caesius. The exact mechanism of the antitumour activity of doxorubicin is not known. It is generally believed that inhibition of DNA, RNA and protein synthesis is responsible for the majority of the cytotoxic effects.

Read about Doxorubicin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
L01DB01
Doxorubicin
L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01D Cytotoxic antibiotics and related substances → L01DB Anthracyclines and related substances
Discover more medicines within L01DB01

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
FR
Base de données publique des médicaments
Identifier(s): 64367525, 65771499
TN
Direction de la Pharmacie et du Médicament
Identifier(s): 10803201H, 10803202H